Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print

Financial Reports

Related Searches:

Filter by:

Financial Report: Pfizer
January 29, 2013
Revenues down 7% in the quarter   Read More »
Financial Report: Lilly
January 29, 2013
Zyprexa decline offset by other product growth   Read More »
Financial Reports: Biogen Idec
January 28, 2013
MS franchise continues growth trend   Read More »
Financial Report: Covance
January 25, 2013
Late-Stage revenues up 16% in the quarter   Read More »
Financial Report: Baxter
January 24, 2013
BioScience revenues up 7% in the quarter   Read More »
Financial Report: Bristol-Myers Squibb
January 24, 2013
Avapro, Plavix patent expirations hurt results   Read More »
Financial Report: Amgen
January 24, 2013
Revenues up 11% in the quarter and FY   Read More »
Financial Report: Abbott
January 23, 2013
Debt resolution impacts earnings   Read More »
Financial Report: Novartis
January 23, 2013
Sales growth offsets Diovan patent expiry   Read More »
Financial Report: Johnson & Johnson
January 22, 2013
Revenues up 8% in the quarter   Read More »
Financial Report: BASi
December 28, 2012
Restructuring charges impacts results   Read More »
Financial Results: Patheon 4Q12
December 17, 2012
CMO revenues up 18% in the quarter   Read More »
Financial Report: WuXi Pharma Tech 3Q
November 13, 2012
Lab Services up 26%, driven by China-based labs   Read More »
Financial Report: BioClinica 3Q
November 8, 2012
Service revenues reach a record $19.2 million   Read More »
Financial Report: Evotec 3Q
November 8, 2012
Revenues decline in the quarter, up 8% YTD   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: